Corporate funding for academic research has been increasing across all fields of clinical
medicine and science [
]. Formal, explicitly defined institutional relationships between an academic unit
(e.g., department, center, organized research unit) and a corporate research sponsor
range from corporate sponsorship of the entire academic unit to a ban on corporate
funding. Academic units that allow individual faculty to receive corporate research
sponsorship, but have no formal relationships with a sponsor at the level of the unit
can be considered “traditional” departments. Examples of formal institutional relationships
between universities and corporate funders include:
- •Corporate funded department (e.g., Novartis funding of University of California Berkeley Department of Plant and Microbial Biology)[[2]]
- •Corporate funded academic research center (e.g., Harvard Center for Risk Analysis)
- •Research center with a mix of corporate funding and government funding (e.g., California Institute for Quantitative Biomedical Research [QB3]). The California Institute for Quantitative Biomedical Research (QB3) is a cooperative effort between the state of California, the University of California campuses at Berkeley, San Francisco, and Santa Cruz, and industry and venture capital partners (http://www.qb3.org/partners.htm).
- •Funding mechanisms that require collaboration with industry (e.g., The Office of Technology administers the Small Business Innovation Research [SBIR] Program and the Small Business Technology Transfer [STTR] Program.)
- •University-based start-up companies (e.g., nonpublicly traded companies focused on developing a few products)
- •Total bans on acceptance of research funding (e.g., Harvard University School of Public Health tobacco industry funding ban)
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Clinical EpidemiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Science in the private interest.Rowan & Littlefield, Lanham, MD2003
- Berkeley teams up with Novartis in $50m plant genomics deal.Nature. 1998; 396: 5
- Tobacco industry manipulation of research.Public Health Rep. 2005; 120: 200-208
- Policies and positions of other organizations on the funding controversy.TRDRP Newsletter Burning Issues. 2001; 4 (continued on page 4): 2
- UK universities agree protocol for tobacco company funding.BMJ. 2004; 329: 9
- Terms and conditions and administration information for research grants and awards.Cancer Research UK, London2007
- Harvard School of Public Health faculty votes not to accept funds from the tobacco companies and subsidiaries.Harvard School of Public Health, Boston, MA2002
- Institutional addiction to tobacco.Tob Control. 1999; 8: 70-74
- Accepting tobacco funding for research: an overview of the issues.TRDRP Newsletter Burning Issues. 2003; 6 (continued on page 10): 7
- Corporate corruption of science and its effects on workers and the environment.Int J Occup Environ Health. 2005; 11: 331-337
- The silence: The asbestos industry and early occupational cancer research—a case study.Am J Public Health. 1991; 81: 791-800
- Deceit and denial: the deadly politics of industrial pollution.University of California Press, Berkeley, CA2002
- Warnings unheeded: a history of childhood lead poisoning.Am J Public Health. 1989; 79: 1668-1674
- Vinyl chloride: a case study of data suppression and misrepresentation.Environ Health Perspect. 2005; 113: 809-812
- Responsible conduct of research.Oxford University Press, New York, NY2003
- Arbitrator tells U. of Delaware to allow grant requests to ‘racist’ fund.in: Chronicle of Higher Education. 1991 (Available at http://chronicle.com (Sept 4, 1991))
- Accepting tobacco industry money for research: has anything changed now that harm reduction is on the agenda.Addiction. 2006; 101 ([Editorial]): 1067-1069
- Will the next generation of “safer” cigarettes be safer?.J Pediatr Hematol Oncol. 2005; 27: 543-550
- Philip Morris's Project Sunrise: weakening tobacco control by working with it.Tobacco Control. 2006; 15: 215-223
- Inside the triple helix: technology transfer and commercialization in the life sciences.Health Aff (Millwood). 2004; 23: 64-76
- Bayh-Dole: almost 25.Science. 2005; 307: 1375
- The demise of Bayh-Dole protections against the Pharmaceutical Industry's abuses of government-funded inventions.J Law Med Ethics. 2004; 32: 777-783
- Bayh-Dole: if we knew then what we know now.Nat Biotechnol. 2006; 24: 320-323
- Research and the Bayh-Dole act.Science. 2004; 303: 40
- Intellectual property. University licensing and the Bayh-Dole Act.Science. 2003; 301: 1052
- Academic medical centers' standards for clinical-trial agreements with industry.N Engl J Med. 2005; 352: 2202-2210
- Defining financial conflicts and managing research relationships: an analysis of university conflict of interest committee decisions.Sci Eng Ethics. 2007; 13: 415-435
- Assessing faculty financial relationships with industry: a case study.JAMA. 2000; 284: 2209-2214
- Financial conflict-of-interest policies in clinical research: issues for clinical investigators.Acad Med. 2003; 78: 769-774
- The implementation of financial disclosure policies to manage conflicts of interest.Health Affairs. 2004; 23: 206-214
- Data withholding in genetics and the other life sciences: prevalences and predictors.Acad Med. 2006; 81: 137-145
- Data withholding in academic genetics: evidence from a national survey.JAMA. 2002; 287: 473-480
- Data withholding and the next generation of scientists: results of a national survey.Acad Med. 2006; 81: 128-136
- Scientific quality of original research articles on environmental tobacco smoke.Tob Control. 1997; 6: 19-26
- Why review articles on the health effects of passive smoking reach different conclusions.JAMA. 1998; 279: 1566-1570
- Implications of the tobacco industry documents for public health and policy.Annu Rev Public Health. 2003; 24: 267-288
- Pharmaceutical industry sponsorship and research outcome and quality: systematic review.BMJ. 2003; 326: 1167-1170
- Scope and impact of financial conflicts of interest in biomedical research: a systematic review.JAMA. 2003; 289: 454-465
- The quality of drug studies published in symposium proceedings.Ann Intern Med. 1996; 124: 485-489
- Authors' financial relationships with the food and beverage industry and their published positions on the fat substitute Olestra.Am J Public Health. 2003; 93: 664-669
- Relationship between funding source and conclusion among nutrition-related scientific articles.PLoS Med. 2007; 4: e5
- Influences on the quality of published drug studies.Int J Technol Assess Health Care. 1996; 12: 209-237
- Policies on faculty conflicts of interest at US universities.JAMA. 2000; 284: 2203-2208
- Conflict of interest and the public trust.JAMA. 2000; 284: 2237-2238
- Ethics issues in academic-industry relationships in the life sciences: the continuing debate.Acad Med. 1996; 71: 1291-1296
- Perception, reality, and the political context of conflict of interest in university-industry relationships.Acad Med. 1996; 71: 1297-1304
- Understanding financial conflicts of interest.N Engl J Med. 1993; 329: 573-576
- Withholding research results in academic life science: evidence from a national survey of faculty.JAMA. 1997; 277: 1224-1228
- Looking a gift horse in the mouth: corporate gifts supporting life sciences research.JAMA. 1998; 279: 995-999
- Effects of patents and licenses on the provision of clinical genetic testing services.J Mol Diagn. 2003; 5: 3-8
- The tobacco industry as a funder of scientific research: isn't that like leaving the fox in charge of the hen house?.TRDRP Newsletter Burning Issues. 2001; 4 (continued on page 5): 3
- Tobacco industry funding: implications for the scientific community.TRDRP Newsletter Burning Issues. 2001; 4 (continued on page 5): 1
- Universities and tobacco money: some universities are accomplices in the tobacco epidemic.BMJ. 2001; 323: 1-2
- Mechanisms of Moral Disengagement.in: Reich W. Origins of terrorism: psychology, ideologies, states of mind. Cambridge University Press, Cambridge, MA1990
- Mechanisms of moral disengagement in the exercise of moral agency.J Pers Soc Psychol. 1996; 71: 364-374
- Moral disengagement in the perpetration of inhumanities.Pers Soc Psychol Rev. 1999; 3: 193-209
- Corporate transgressions through moral disengagement.J Hum Values. 2000; 6: 57-64
- Chasing the dollar: why scientists should decline tobacco industry funding.J Epidemiol Community Health. 2003; 57: 546-548
Article info
Publication history
Accepted:
January 8,
2008
Identification
Copyright
© 2008 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
